Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 2006 Top 10 Biopharmaceutical Companies Report | Contract Pharma
Features

2006 Top 10 Biopharmaceutical Companies Report

Amgen continues to rule the Top 10 Biopharma rankings, but 2005 saw a couple of players make great strides. Genentech and Gilead continued to post huge gains (+46% each) on the strength of their oncology and HIV drugs, respectively.

 



Photo courtesy of Genzyme

Top 10 Biopharma Companies Report

Amgen continues to rule the Top 10 Biopharma rankings, but 2005 saw a couple of players make great strides. Genentech and Gilead continued to post huge gains (+46% each) on the strength of their oncology and HIV drugs, respectively.

Chiron also eked its way back into the billion-dollar ranks after its vaccine-manufacturing disaster in 2004, but it wasn’t enough to help the company stay independent; the company was bought by Novartis and will disappear from this chart next year.
—Gil Y. Roth
Editor
Contributors

Editor:    Gil Y. Roth
Associate Editor:    Kristin Brooks
Contributing Editor:    Derek B. Lowe

Top 10 Biopharmaceutical Companies

based on 2005 biopharma revenues

1  Amgen $12,022
2  Genentech $5,488
3  Serono $2,339
4  Biogen Idec $2,326
5  Gilead Sciences $1,809
6  Genzyme Corp. $1,773
7  MedImmune $1,221
8  Chiron Corp. $1,138
9  Millennium Pharmaceuticals $316
10  ImClone $221

2005 R&D Expenditures

1  Amgen $2,314
2  Genentech $1,262
3  Biogen Idec $747
4  Serono $594
5  Genzyme Corp. $503
6  Chiron Corp. $434
7  MedImmune $385
8  Millennium Pharmaceuticals $342
9  Gilead Sciences $278
10  ImClone $99


Note: In all Top Company profiles, dollar amounts are in millions.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters